Cryoablation of Intercostal Nerves for Better Control of Postoperative Pain After Thoracic and Thoracoabdominal Open Surgery

Sponsor
Germano Melissano (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05153083
Collaborator
(none)
200
13
28
15.4
0.5

Study Details

Study Description

Brief Summary

The purpose of the registry is to evaluate the peri-operative and short- term outcomes of intercostal nerves cryoablation for post-operative pain control after open thoracic and thoracoabdominal aortic aneurysms repair.

The cryoablation procedure is one of the opportunities for pain control after thoracotomy. So, it is routinely performed in major several centers in aortic surgery around the world as a part of the TAA and TAAA procedure.

The Registry will include approximately 200 patients treated from January 2022 to January 2024 for thoracic or thoracoabdominal aortic aneurysm by means of open surgery and in whom intraoperative intercostal nerves cryoablation will be performed; to reach 200 patients, the enrolments can be extended until January 2027.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Open thoracic (TAA) and thoracoabdominal aortic aneurysms repair (TAAA)

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Cryoablation of Intercostal Nerves for Better Control of Postoperative Pain After Thoracic and Thoracoabdominal Open Surgery - A Physician-initiated, International, Multicentre, Prospective, Observational Registry of Patients Undergoing Open Thoracic (TAA) and Thoracoabdominal Aortic Aneurysms Repair (TAAA) Using Cryoablation of Intercostal Nerves to Improve Postoperative Pain Control. (Cryo Registry)
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
patient undergoing open thoracic (TAA) and thoracoabdominal aortic aneurysms repair (TAAA)

Subjects undergoing open thoracic (TAA) and thoracoabdominal aortic aneurysms repair (TAAA) using cryoablation of intercostal nerves

Procedure: Open thoracic (TAA) and thoracoabdominal aortic aneurysms repair (TAAA)
Each participating center will be able to use its preferred European Conformity marked device, for cryoablation according to their normal clinical practice and according to the instructions for use.

Outcome Measures

Primary Outcome Measures

  1. technical success [From Admission to 1 years]

    Freedom from Death

  2. change in dose of narcotic administration [From Admission to 1 years]

    reduction opioids usage for thoracic incision pain

  3. Primary clinical success [up to 3 weeks]

    pain control defined as a visual analogic scale < 5 in the perioperative period up to the discharge

  4. secondary clinical success [up to 3 weeks]

    pain control in in the perioperative period up to the discharge, using analgesic non opioids drugs

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients ≥18 years

  • Patients who will undergo TAA and TAAA open repair with intraoperative intercostal nerves cryoablation

  • Subject has consented for study participation and signed the approved Informed Consent

Exclusion Criteria:
  • Patients with active systemic or cutaneous infection or inflammation

  • Patients who are pregnant or breastfeeding

  • Patients younger than 18 years of age

  • Unwilling or unable to comply with the follow-up schedule

  • Inability or refusal to give informed consent

  • Frank rupture

  • Previous stroke with neurological sequelae

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Hietzing,Vienna Vienna Austria
2 Salpetriere University Hospital Paris France
3 University Hospital Freiburg Freiburg Germany
4 University Medical Center Hamburg-Eppendorf Hamburg Germany
5 University Medical Center Hamburg Hamburg Germany
6 Hannover Medical School Hannover Germany
7 Saarland University Hospital Homburg Germany
8 Policlinico S. Orsola - Malpighi Bologna Italy
9 Fondazione Policlinico Universitario Agostino Gemelli IRCCS Roma Italy
10 Maastricht University Medical Center Maastricht Netherlands
11 Centro Hospitalar de Entre o Douro e Vouga Santa Maria Da Feira Portugal
12 University Hospital of Bern Bern Switzerland
13 St Bartholomew's Hospital London United Kingdom

Sponsors and Collaborators

  • Germano Melissano

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Germano Melissano, Prof, IRCCS San Raffaele
ClinicalTrials.gov Identifier:
NCT05153083
Other Study ID Numbers:
  • Cryo Registry
First Posted:
Dec 10, 2021
Last Update Posted:
Aug 3, 2022
Last Verified:
Aug 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 3, 2022